Expansion improves capacity to respond to dangerous pathogens and strengthens domestic public health and safety
WINNIPEG, July 20, 2017 /CNW/ - The Government of Canada is committed to protecting the health and safety of Canadians through enhanced public health security. Enhancements to Canada's Containment
Today, the Honourable Jane Philpott, Minister of Health, announced a reconfiguration project at the Canadian Science Centre for Human and Animal Health that will convert existing laboratory space to the highest level of biosafety CL4. This $5 million project will reconfigure adjacent high containment lab areas within the existing footprint of the building.
The increased CL4 lab space will improve Canada's capacity to detect and respond to the growing number of emerging human and animal pathogens such as Ebola, Middle East Respiratory Syndrome, and new types of avian influenza. It will allow the Government of Canada to respond in a timely and proactive manner to increasing global demands for investigating, testing and researching high risk infectious diseases.
The Canadian Science Centre for Human and Animal Health co-houses the Public Health Agency of Canada's National Microbiology Laboratory (NML) and the Canadian Food Inspection Agency's National Centre for Foreign Animal Disease (NCFAD).CL4 laboratories have highly specialized construction and engineering controls and are equipped to safely diagnose, research, and develop treatments and vaccines for high risk pathogens, such as Ebola and Nipah virus.
"The Government of Canada is committed to strengthening Canada's research and science base by investing in infrastructure at federal laboratories. We are proud to support our world-class researchers by providing them with the tools they need to protect the health of Canadians." The Honourable Jane PhilpottMinister of Health
"The Canadian Science Centre for Human and Animal Health is a world class research centre with a mission to advance human and animal health through laboratory leadership, scientific excellence, and public health innovation. Expanding our CL4 laboratory space vastly increases our capacity to investigate, test, and research the most deadly of infectious diseases." Dr. Theresa TamChief Public Health Officer, PHAC
SOURCE Public Health Agency of Canada
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All